Literature DB >> 19448928

[Assessment of adherence to antiretroviral drugs in a municipality in southern Brazil].

Carine Raquel Blatt1, Cecília Bathke Citadin, Fernanda Gaspar de Souza, Rogério Sobrosa de Mello, Dayani Galato.   

Abstract

The aim of this research is to assess predicting factors and adherence levels to antiretrovirals through self-report and the date of drug retrieval. It is a transversal study in which 67 patients were interviewed. Patients who used more than 90% of doses were considered to have complied with the treatment. Results of adherence were: self-reports (72.7%); calculated using dosage forgotten on the last day (70%); in three (76.1%) days; in seven (80.5%) days; and in fifteen (80.5%) days; calculated using the date of drug retrieval in a period of three (53.7%) months; and in six (47.8%) months. Variables significantly associated with adherence were: educational level, living with the family, refer good adherence, positive assessment of the antiretroviral therapy, a diagnosis of an opportunistic disease, NADIR greater than 200 cells/mm(3) and being in first-time treatment. To improve adherence rates individual and collective strategies should be elaborated taking into account factors which have been identified as negatively effecting adherence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448928     DOI: 10.1590/s0037-86822009000200007

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

1.  MORBIDITY AND MORTALITY DUE TO AIDS: A STUDY OF BURDEN OF DISEASE AT A MUNICIPAL LEVEL.

Authors:  Jane Da Silva; Victoria Ramos; Helena Caetano Gonçalves Da Silva; Jefferson Traebert
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Sep-Oct       Impact factor: 1.846

Review 2.  Socioeconomic factors in adherence to HIV therapy in low- and middle-income countries.

Authors:  Karl Peltzer; Supa Pengpid
Journal:  J Health Popul Nutr       Date:  2013-06       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.